Stull DE, Houghton K. Examining variability in depression among pre-retirees: innovative analytic methods applied to observational data. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A301.
Arana A, Arellano F, Suissa S. Suicide-related events in patients treated with antiepileptic drugs: not an example of time-window bias [Comment]. Epidemiology. 2011 Nov;22(6):876-7.
Karve S, Markowitz M, Panish J, Candrilli S, Cosmatos I, Alphs L. Assessing health care utilization and costs among hospital-discharged patients with schizophrenia. Poster presented at the 2011 US Psychiatric and Mental Health Congress; November 2011.
Huybrechts KF, Brookhart MA, Rothman KJ, Silliman RA, Gerhard T, Crystal S, Schneeweiss S. Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol. 2011 Nov 1;174(9):1089-99.
Ascher-Svanum H, Novick D, Haro J, Aguado J, Cui Z, Anand H. Empirically-driven definitions of 'good', 'moderate' and 'poor' levels of functioning in the treatment of schizophrenia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A287. doi: 10.1016/j.jval.2011.08.307
Bell C, McLeod LD, Nelson LM, Fehnel SE, Zografos LJ, Bowers B. Development and psychometric evaluation of a new patient-reported outcome instrument measuring the functional impact of insomnia. Qual Life Res. 2011 Nov 1;20(9):1457-68.
Markowitz M, Karve S, Panish J, Candrilli S, Cosmatos I, Alphs L. Evaluating antipsychotic adherence patterns among Medicaid-enrolled hospital-discharged patients with schizophrenia. Poster presented at the Psychiatric and Mental Health Congress; November 2011.
Coon CD, Nelson LM, Gilligan T. Advanced psychometric methods for PRO development – factor analysis. Presented at the 18th Annual Conference for the International Society for Quality of Life Research; October 2011.
Gili M, Luciano JV, Bauzá N, Aguado J, Serrano MJ, Armengol S, Roca M. Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in Spanish population. BMC Med Res Methodol. 2011 Sep;21(11):131.
López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. The pattern of use of anti-depressant drugs in a pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S101.
López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. Adherence to antidepressant treatment among pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S316.
Gonzalez-Pinto A, Vieta E, Reed C, Novick D, Barraco A, Aguado J, Haro JM. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM). J Affect Disord. 2011 Jun;131(1-3):320-9.
Karve SJ, Panish J, Dirani R, Candrilli SD. Annual health care costs for patients with schizophrenia experiencing multiple relapses after initiation of a second-generation oral antipsychotic. Poster presented at the 164th Annual Meeting of the American Psychiatric Association; May 2011.
Panish J, Karve S, Candrilli S, Dirani R. Association between adherence and persistence with antipsychotics and outcomes among Medicaid patients with schizophrenia. Poster presented at the 164th Annual Meeting of the American Psychiatric Association; May 2011.
Lançon C, DiBenedetti DB, Lewis SA, Davis KH, Danchenko N, François C. Assessing the impact of major depressive disorder (MDD) on family functioning: development of the depression and family functioning scale. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A195.
Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Can Med Assoc J. 2011 Apr 1;183(7):E411-9.
Forns J, Torrent M, Garcia-Esteban R, Caceres A, Gomila MP, Martinez D. 4-year-old neurodevelopment and early life determinants are longitudinally associated to 11-year-old attention function. Poster presented at the 23rd Congress of International Society of Environmental Epidemiology (ISEE); 2011. Barcelona, Spain.